WeVote
Log In

Bill

Bill

HR 88

A RESOLUTION encouraging the Kentucky Department for Public Health, in conjunction with the Kentucky Office of Drug Control Policy, to issue a public statement to increase awareness in the Commonwealth on the potential harm of consuming 7-hydroxymitragynine products.

2025 Regular Session

Kentucky House urges public health agencies to issue a warning about potential harms of 7-hydroxymitragynine products to increase consumer awareness.

adopted by voice vote
#drugsandmedicines #governor #publichealth #stateagencies
0
WeVote Research Nonpartisan
Bill Summary · HR 88

Legislative bill overview

HR 88 is a non-binding resolution that urges Kentucky's Department for Public Health and Office of Drug Control Policy to jointly issue a public awareness statement about the potential health risks of consuming 7-hydroxymitragynine (a compound found in kratom). The resolution passed the House by voice vote on March 28, 2025, and has no enforcement mechanism.

Why is this important

7-hydroxymitragynine is an alkaloid derived from kratom, a botanical substance with opioid-like effects that has grown in popularity as a legal alternative to prescription opioids. As kratom products have proliferated in Kentucky and nationwide, public health officials face questions about their safety, potential for addiction, and unregulated manufacturing standards. This resolution reflects legislative concern about informing the public about potential health risks, particularly in a state affected by opioid misuse.

Potential points of contention

  • Kratom's legal and safety status remains disputed: Scientific evidence on kratom's health effects is incomplete, and it remains legal federally and in Kentucky; some view this resolution as appropriately cautious while others see it as premature or stigmatizing of a substance some use medicinally.
  • Resource allocation and specificity: The resolution requests a public statement but provides no funding or detailed guidance on what that statement should contain, potentially limiting its practical impact or creating confusion about kratom's actual risks versus theoretical ones.
  • Regulatory versus informational approach: Critics may argue the state should either regulate kratom products directly or remain neutral; supporters may view public awareness as a reasonable middle ground that doesn't restrict access.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.